Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Grants
  • About Akademiliv

OligoNova HUB – Innovative Development of a New Class of Drugs

22 April, 2022

INFRASTRUCTURE. OligoNova Hub is Sweden’s new national infrastructure for drug development, specifically focused on therapeutic oligonucleotides. Here, researchers with expertise in e.g. bioinformatics, chemistry and cellular biology will work with innovative development projects of drugs for patient groups that currently lack appropriate treatment.

Pär Matsson, professor of pharmacokinetics at the Department of Pharmacology, Sahlgrenska Academy, is head of the OligoNova Hub.

Pär Matsson, professor vid Department of Pharmacology
at the Institute of Neuroscience and Physiology. Photo: Josefin Bergenholtz.

“My research focuses on drug development, especially how to optimize new classes of drugs so that they reach the specific cells and targets that they are intended to affect. OligoNova Hub’s focus is in-line with my research expertise, and it feels very exciting to be involved in building a national pharmaceutical infrastructure from scratch,” Pär said.

Resource and competence in drug development

The OligoNova HUB’s mission is to support academic research with resources and expertise in the field of drug development.

“Our goal is to help researchers convert their research results into new drugs for patient groups that currently lack appropriate treatment.”

In the first phase, the hub will consist of 8-10 employees, but in the long term, additional team members are to be recruited.

Cooperation Between University and Industry

The hub is organizationally part of Core Facilities at the University of Gothenburg. At the same time, it is part of SciLifeLab’s national drug platform (DDD) and is located in AstraZeneca’s BioVentureHub in Mölndal.

Pär Matsson emphasized that this will enable a broad and important collaboration between universities and industry – which is central to continued world-leading pharmaceutical research in Sweden.

“AstraZeneca have the past years invested in the development of therapeutic oligonucleotides. Now that OligoNova Hub is co-located with AstraZeneca in Mölndal, there will naturally be opportunities for collaboration and for productive discussions with their experts in the field.”

Within the Core Facilities platforms, expertise that is central to drug development projects at OligoNova Hub are already available, for example in areas like proteomics, imaging, bioinformatics, protein production and genomics. Pär also mentions that the Swedish NMR Centre is located nearby at GU, which also gives a great advantage.

“As a newly started platform, we can both use established expertise, instruments and existing project flows, while at the same time contribute to adding new technology and a new class of drugs to the research,” Pär said.

Call for therapeutic oligonucleotide projects

In a call for projects, the HUB is currently looking for project ideas for new therapeutic oligonucleotides. The call is open for scientists with a doctoral degree at a Swedish university or higher institution.

 

READ FURTHER

  • OligoNova Hub
  • Oligonova.org
  • News article about the first face-to-face OligoNova Network conference: OligoNova sets up first gathering of top Swedish oligonucleotide scientists

BY: CHARBEL SADER

By: Elin Lindström
Tagged With: institutionen för neurovetenskap och fysiologi

HAPPY SUMMER!

The newsletter from Akademiliv will return on Wednesday, August 21st.

Contact your institute to add your event to the calendar in the Staff Portal

  • Biomedicine: Kristian Kvint: kalender@biomedicine.gu.se
  • Core Facilities: Amelie Karlsson: amelie.karlsson.2@gu.se
  • Clinical Sciences: Katarina Olinder Eriksson: klinvet@gu.se
  • Medicine: Nina Raun; kommunikation@medicine.gu.se
  • Neuroscience and Physiology: Josefin Bergenholtz; kommunikation@neuro.gu.se
  • Odontology: Johan Thompson; info@odontologi.gu.se
  • Sahlgrenska Academy’s Office and faculty-wide calendar events Åsa Ekvall; info@sahlgrenska.gu.se
  • Health and Care Sciences: Karin Mossberg; vardvetenskap@fhs.gu.se

Information from Sahlgrenska Academy Research Support Office

[UPDATED JUNE 2024]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated on a monthly basis.
Current and previous newsletters are also available in the Staff Portal.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

More news

En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book

27 May, 2024

NEW BOOK. During his career as a physician specializing in internal medicine, Björn Fagerberg has been involved in many end-of-life situations, …  

She is doing her residency in the US with a medical degree from Gothenburg

21 May, 2024

STUDENT. Doing a “residency” in orthopedics in the United States is an unattainable dream for many newly qualified American doctors. Now Janina Ka …  

Alba Corell reports from a high-level brain tumor meeting

20 May, 2024

COLUMN. The recent gathering of the Scandinavian Society of Neuro-oncology (SNOG) in Gothenburg has concluded. Professor Asgeir Jakola hosted and …  

From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health

17 May, 2024

GLOBAL HEALTH. In the bustling Tygerberg University Hospital in Cape Town, a dedicated research team led by Lina Bergman, is on a mission to …  

Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024

17 May, 2024

AWARD. The Assar Gabrielsson Foundation has named Anna Wenger as the winner in the basic science research category and Sara Bjursten as the …  

A full day for PhD students focused on mental health

16 May, 2024

PHD STUDENTS. For the sixth time, PhD students at Sahlgrenska Academy were invited to PhD Day, organized by the Doctoral Student Council. The day …  

Kaj Blennow ranked highest in Sweden in neuroscience

16 May, 2024

AWARD. In this year's edition of the researcher ranking from Research.com in the field of neuroscience, Kaj Blennow is ranked 17th …  

Linda Wass is doing a postdoc at Stanford with ALF funding

14 May, 2024

ALF FUNDING. Biomedical Scientist Linda Wass has just settled in Stanford, California, where she will spend two years as a postdoc. She is the …  

Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023

14 May, 2024

AWARD. Karin Nilsson, currently a postdoc at the Department of Internal Medicine and Clinical Nutrition, receives the faculty-wide Thesis of the …  

Some answers from the proposed members of the next Faculty Board

14 May, 2024

FACULTY ELECTIONS. The eight proposed members of the next Faculty Board hereby give some brief answers on how they want to contribute to the work …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen